It works with your body to help rebuild lost collagen.
Sculptra Aesthetic is an FDA-approved injectable that helps gradually replace lost collagen—the most common protein in the body that is used to form a framework to support cell and tissue—for results that can last more than two years.
Sculptra is an injectable dermal filler that is used for volume restoration as well as to correct shallow-to-deep facial wrinkles and folds that appear with aging. Sculptra is made from poly-L-lactic acid, which helps to replace lost collagen. The material is a biocompatible, biodegradable synthetic molecule that has been safely used by physicians for decades. The medication is injected below the skin, above the fat, to treat folds and wrinkles, correct facial asymmetry, add volume to thin cheeks and midface, and to reduce hollowness of the temples. Sculptra is FDA approved for both cosmetic use (Sculptra Aethetic) and to treat HIV-associated lipodystrophy. Sculptra is a facial injectable that gives you subtle results over time, giving you natural-looking restoration, without giving you away. For optimal results, an average of three to four injection sessions over a few months is usually needed, with results that often last more than two years.
Benefits |
|
---|---|
FAQs | N/A |
Treatment Type | Injectables |
Treatment Problem or Condition | Facial Volume Loss, Fine Lines, Sagging/Loose Skin, Wrinkles |
Size | Sold per Vial |
Brand | Sculptra |
SCULPTRA Aesthetic is indicated for use in immune-competent people as a single regimen for correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles in which deep dermal grid pattern (cross-hatch) injection technique is appropriate.
Sculptra Aesthetic should not be used by people that are allergic to any ingredient of the product or have a history of keloid formation or hypertrophic scarring. Safety has not been established in patients who are pregnant, lactating, breastfeeding, or under 18 years of age.
SCULPTRA® Aesthetic is an injectable implant containing microparticles of poly-L-lactic acid (PLLA), carboxymethylcellulose (USP), non-pyrogenic mannitol (USP) and sterile water for injection (USP).